Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Here’s a calculation

<< Previous

Bullboard Posts

Next >>

Post by GoldMemberTon Nov 15, 2021 4:57pm

253 Views

Post# 34129190

Here’s a calculation

How many more years at 0.6 patients per month enrolment until the trial hits 60% for you to even get a sense if maybe the trial data is maybe good.

Or even better you're still possibly until the end of Q1 until DIMI trial even starts. Given their CONSTANT missed deadlines you'll be lucky if it starts next fall.

Why are you working so hard to pay everyone else salaries... or is there something else to it?

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market